LIGNAN ANTITUMOR PROTOTYPES VIA DIANION INTERMEDIATES

NIH RePORTER · NIH · R01 · $52,780 · view on reporter.nih.gov ↗

Abstract

The specific goal of this proposal is the synthesis of a series of increasingly challenging lignan natural products culminating in the efficient preparation of two antitumor prototypes: steganacin and podophyllotoxin. Development of such sequences should prove especially useful for exploration of structure-activity relationships among analogs to these promising agents. Dianion intermediates exhibit extraordinary reactivity towards electrophiles. Preliminary studies have demonstrated that carboxylic acid dianions can be either dimerized or iodinated simply by varying the stoichiometry of added I2. Building upon this simple transformation, numerous symmetrically- and unsymmetrically-submitted succinic acid derivatives (including anhydrides, lactones, and amides) become readily available. Key synthetic steps to be explored in the generation of both steganacin and podophyllotoxin include reaction of amide dianions with 2-iodocarboxylates, selective reduction of the resulting acid-amide products, and intramolecular photochemically-driven iodination using N-iodoamide precursors.

Key facts

NIH application ID
3179644
Project number
5R01CA040105-03
Recipient
UNIVERSITY OF CINCINNATI
SAM.gov UEI
DZ4YCZ3QSPR5
Principal Investigator
JOHN L BELLETIRE
Activity code
R01
Funding institute
NIH
Fiscal year
1987
Award amount
$52,780
Award type
5
Project period
1985-09-30 → 1989-07-31